High-Risk Payment Gateway for Nutra, SARMs, Kratom, CBD, and Supplements

"High-risk payment gateway" is a category every nutraceutical, SARMs, kratom, kava, nootropic, CBD, and supplements merchant meets by week three of going live. Stripe disappears. PayPal freezes. Square off-boards. The merchant category code for supplements (MCC 5122), herbs / kratom (often coded 5499), or SARMs / research compounds (also 5122) lands you on the Visa and Mastercard restricted-business radar — and from the mainstream PSPs' perspective, the math says ban-first. The traditional fix is a high-risk PSP: CCBill, AllayPay, PayKings, Instabill, SanctusPay. Those work, eventually, at the cost of 5–10% fees, $5k–$50k rolling reserves, 2–4 weeks of underwriting, and an LLC + bank-statement stack you may not have yet. This guide breaks down what a high-risk payment gateway actually is for nutra / SARMs / kratom verticals, compares the incumbents, and introduces the 2026 non-custodial alternative: Peptide-Pay at 3% flat, no LLC, no reserve, same-day go-live — built for peptides but structurally identical for every adjacent restricted supplement vertical.

What makes a payment gateway "high-risk"?

The term "high-risk" is imprecise in casual use but specific at the card-network level. Visa and Mastercard maintain an internal classification of merchants into two tiers:

1. Standard merchant: chargeback ratio below 0.9% and not in a restricted MCC. Default pricing, no special monitoring.
2. High-risk merchant: chargeback ratio above 0.9%or operating in a restricted MCC orin a tier-2 vertical monitored under Visa's Integrity Risk Program (VIRP) or Mastercard's BRAM / Excessive Chargeback Program. Fees rise, reserves are required, and the acquirer faces fines if chargebacks spike.

Restricted-MCC verticals are structurally high-risk regardless of their actual chargeback rate. Nutra, SARMs, kratom, and CBD sellers with pristine 0.1% chargeback rates are still in the high-risk tier because of their MCC — which is why mainstream PSPs auto-reject them regardless of track record.

Incumbent high-risk PSPs: CCBill, AllayPay, PayKings, Instabill

The high-risk PSP market is an old industry with a small number of long-standing incumbents. Four consistently appear in nutra / SARMs / kratom shortlists:

• CCBill: founded 1998, primarily adult-industry but accepts nutra and some SARMs. 5.5–10.75% processing fees, $5k+ rolling reserve, 2-week onboarding, US + EU coverage.
• AllayPay: specialist in nutra / CBD / supplements. 5–9% fees, sliding reserve (often 10% held for 180 days), 1–3 week onboarding.
• PayKings: broker-style — shops you around to acquiring banks on their panel. 6–9% fees, 10% reserve, 2-week onboarding for nutra.
• Instabill: older nutra / adult shop. 6–12% fees, high reserves, 4-week onboarding for new merchants.
• Offshore PSPs (Paybilt, EMerchantPay, SMP): cheaper fees (4–7%) but payout to offshore bank accounts only, and correspondent-bank fragility — payouts can be delayed or reversed weeks after the transaction.

All five require an existing LLC + bank account + processing history before underwriting — exactly what a pre-incorporation indie founder does not have.

What high-risk PSP underwriting actually asks for

Applying to a high-risk PSP in 2026 is significantly more paperwork- heavy than applying to Stripe. A typical underwriting package:

• Articles of incorporation (LLC, LTD, SAS, or GmbH — corporate shell required).
• Owner/officer personal ID + proof of address.
• Business bank account statements, 3–6 months.
• Existing card-processing statements, 6–12 months. (Yes, they expect you to already be processing card payments somewhere — often with a previous high-risk PSP.)
• Business license / professional license where applicable.
• Chargeback history and reasons, per transaction.
• Website and fulfillment details, shipping provider details.
• Personal guarantee from the principal — exposes your personal assets if the merchant fails.

For a solo indie dev launching their first nutra / SARMs / kratom shop, the underwriting package is a non-starter — the "6 months of card-processing statements" requirement alone forces a chicken-and-egg where you can't get a first PSP because you have no prior PSP history. The result is the Stripe-then-termination-then- high-risk-PSP cycle: merchants launch on Stripe, burn a few weeks of sales, lose their funds to a 180-day reserve, and only then accumulate the processing history a real high-risk PSP will accept.

The non-custodial alternative: 2026 model

The last four years opened a new path. Instead of applying to a high-risk PSP as a merchant (and clearing their underwriting), route payments through an MCC 6051 crypto on-rampthat already has its own acquirer relationships. The card authorization happens on the on-ramp side. Your merchant side receives USDC on-chain. No merchant-account underwriting because there's no merchant account — you're just a wallet receiving USDC.

That's what Peptide-Pay does. The name reflects the primary vertical we built for (peptides + research compounds), but structurally the architecture works identically for every adjacent restricted supplement vertical: nutra, SARMs, kratom, kava, CBD, nootropics. The merchant-side flow is:

1. Sign up, paste a Polygon USDC wallet you personally own.
2. Grab an API key, paste into your shop's env variables.
3. Install the WooCommerce plugin OR drop a single SDK call into your checkout route OR generate a hosted payment link for no-code platforms.
4. Ship. First live sale typically clears under 15 minutes from signup.

// npm install github:kinerette/peptide-pay-sdk
// Works identically for nutra, SARMs, kratom, kava, CBD, peptides,
// nootropics, and other restricted-MCC verticals.
import { PeptidePay } from 'peptide-pay';
const pp = new PeptidePay(process.env.PEPTIDEPAY_API_KEY!);

export async function POST(req: Request) {
  const { orderId, cartTotalCents } = await req.json();
  const session = await pp.checkout.sessions.create({
    amount_cents: cartTotalCents,
    currency: 'USD',
    customer_email: req.headers.get('x-customer-email') ?? undefined,
    success_url: 'https://yourshop.com/thanks',
    cancel_url:  'https://yourshop.com/cart',
    webhook_url: 'https://yourshop.com/api/pp-webhook',
    metadata: { order_id: orderId, vertical: 'nutra' },
  });
  return Response.redirect(session.url, 303);
}

Comparison: Peptide-Pay vs high-risk PSPs vs Stripe for nutra / SARMs / kratom

Compliance: what nutra / SARMs / kratom merchants still owe

Routing around MCC 5122 does not change your legal obligations. You remain the merchant of record for every order. Key compliance items that Peptide-Pay does not handle and that you must implement yourself:

• FDA-style disclaimer wording."This product has not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease." for nutraceuticals in the US. Research-compound disclaimers for SARMs / peptides in research verticals.
• Kratom state-law compliance. Kratom is banned in 6 US states (Alabama, Arkansas, Indiana, Rhode Island, Vermont, Wisconsin) and several counties. Your shipping filter must respect state-level bans.
• CBD / Delta product regulation. State-level variation is severe — check every shipping jurisdiction. Some products are legal federally but banned in specific states; others are the reverse.
• Sales tax / VAT collection.US state nexus, EU OSS / IOSS VAT. Peptide-Pay doesn't handle tax — you add a TaxJar / Avalara / Stripe Tax equivalent on top.
• Age verification. Required for CBD / Delta / kratom in most jurisdictions. Integrate Veratad or equivalent at checkout.

Which nutra / SARMs / kratom merchants fit Peptide-Pay today

Rough breakdown of our current merchant base outside the pure peptide category:

• SARMs research-compound shops: ~15% of total merchants. Same MCC routing logic as peptides; clean fit.
• Kratom and kava: growing quickly in 2026 as NowPayments and similar custodial processors tighten on the category.
• Nootropic stacks: especially those selling prescription-adjacent ingredients (gray-market racetams, phenibut where legal, non-scheduled modafinil analogs).
• Generic nutraceuticals with aggressive claims: testosterone boosters, fat burners, pre-workouts. These often clear Stripe initially and then get shut down on a Radar review.

Poor fits: very small shops doing < $500/month (the 3% flat fee is higher than some crypto-only alternatives at that tier), shops that can't handle their own tax / state-law compliance, and shops attempting to sell controlled substances or prescription-only drugs without proper licensing.

Getting started

1. Sign up. One field — Polygon USDC wallet address.
2. Pick your integration path: payment link / WooCommerce plugin / npm SDK. See Integrate.
3. Ship. See /fees for the full 3% flat breakdown and /how-it-works for the settlement diagram.

Further reading: High-Risk Payment Gateway for Peptides (the peptide-specific version of this article), Stripe Alternative for Peptides, and the Payment Processor for Peptides pillar article.